CXCR4 and neoplasm: Initially, in vivo imaging demonstrated that compared to the oe‐NC group, tumor growth in the oe‐NC+M2pep‐Cs NPs/Plerixafor group was significantly reduced; while, the oe‐CXCR4 group showed increased tumor growth rates.